Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

629 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?
Saposnik G, Goodman SG, Leiter LA, Yan RT, Fitchett DH, Bayer NH, Casanova A, Langer A, Yan AT; Vascular Protection; Guidelines-Oriented Approach to Lipid-Lowering Registries Investigators; Stroke Outcome Research Canada Working Group. Saposnik G, et al. Among authors: leiter la. Stroke. 2009 Apr;40(4):1417-24. doi: 10.1161/STROKEAHA.108.533018. Epub 2009 Feb 12. Stroke. 2009. PMID: 19213947
Statin therapy and the management of acute coronary syndromes.
Langer A, Constance C, Fodor JG, Frohlich JJ, Grégoire J, Lau DC, Leiter LA, Mancini GB, Marr D, McPherson R, O'Neill BJ, Rabkin SW. Langer A, et al. Among authors: leiter la. Can J Cardiol. 2003 Jul;19(8):921-7. Can J Cardiol. 2003. PMID: 12876613 Review.
Effect of individualizing starting doses of a statin according to baseline LDL-cholesterol levels on achieving cholesterol targets: the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study.
Martineau P, Gaw A, de Teresa E, Farsang C, Gensini GF, Leiter LA, Langer A; ACTFAST investigators. Martineau P, et al. Among authors: leiter la. Atherosclerosis. 2007 Mar;191(1):135-46. doi: 10.1016/j.atherosclerosis.2006.03.019. Epub 2006 Apr 27. Atherosclerosis. 2007. PMID: 16643923 Clinical Trial.
Contemporary management of dyslipidemia in high-risk patients: targets still not met.
Yan AT, Yan RT, Tan M, Hackam DG, Leblanc KL, Kertland H, Tsang JL, Jaffer S, Kates ML, Leiter LA, Fitchett DH, Langer A, Goodman SG; Vascular Protection (VP) and Guidelines Oriented Approach to Lipid Lowering (GOALL) Registries Investigators. Yan AT, et al. Among authors: leiter la. Am J Med. 2006 Aug;119(8):676-83. doi: 10.1016/j.amjmed.2005.11.015. Am J Med. 2006. PMID: 16887414
Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration.
Blanco-Colio LM, Martín-Ventura JL, de Teresa E, Farsang C, Gaw A, Gensini G, Leiter LA, Langer A, Martineau P, Egido J; ACTFAST investigators. Blanco-Colio LM, et al. Among authors: leiter la. Am Heart J. 2007 May;153(5):881-8. doi: 10.1016/j.ahj.2007.02.029. Am Heart J. 2007. PMID: 17452168 Clinical Trial.
629 results